SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that ...

Skin cancer cases are rising in India due to more UV exposure and late diagnosis. Experts stress the importance of early ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

Pain, fatigue, and loss of appetite are common symptoms of advanced prostate cancer and its treatment. Here’s what you can do to feel better. Talking to your doctor about any advanced prostate c ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

"This is an interesting review of important technologies for identifying different cancers. Nevisense represents an innovative approach to enhancing early-stage melanoma detection while minimizing ...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face.

Discover how a new study highlights the transformative potential of Th2 immunity in early cancer intervention.